Cat. No. |
Product Name |
Activity |
5619 |
N-Acetylcysteine
amide |
Maintains
HSC function in culture; also GSH precursor; antioxidant |
3979 |
Alexidine
dihydrochloride |
Preserves
functional hematopoietic stem cells ex vivo; also inhibitor of PTPMT1 |
3299 |
AMD
3100 octahydrochloride |
Promotes
HSCs mobilization and expansion |
3194 |
BIO |
Promotes
HSC proliferation; also highly selective GSK-3 inhibitor; acts as Wnt
activator |
5051 |
BIO
5192 |
Promotes
HSCs and progenitor mobilization; also highly potent and selective inhibitor
of integrin α4β1 (VLA-4) |
6047 |
BOP |
Promotes
HSCs mobilization; also α9β1/α4β1 integrin inhibitor |
6996 |
BOP-JF549 |
Yellow
fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to
Janelia Fluor® 549; fluorogenic; photostable |
6997 |
BOP-JF646 |
Red
fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to
Janelia Fluor® 646; fluorogenic; photostable |
7153 |
BRD
0539 |
Cell
permeable and reversible Cas9 inhibitor |
1231 |
Brefeldin
A |
Enhances
CRISPR-mediated HDR efficiency; also disrupts protein translocation to Golgi |
5050 |
CASIN |
Induces
HSC mobilization; also Cdc42 inhibitor; restores cell polarity |
3858 |
CH
223191 |
Promotes
HSCs expansion in vitro; also potent aryl hydrocarbon receptor (AhR)
antagonist |
4423 |
CHIR
99021 |
Promotes
HSC proliferation; also highly selective GSK-3 inhibitor; acts as Wnt
activator |
5331 |
CPI
203 |
Promotes
HSC expansion; also BET Bromodomain inhibitor |
5702 |
DiD
perchlorate |
HSC
stain; also lipophilic fluorescent reagent |
4027 |
16,16-Dimethyl
Prostaglandin E2 |
Regulates
HSC development |
6019 |
Diprotin
A |
Enhances
HSCs viability after harvesting; also dipeptidyl peptidase IV (DPP-IV)
inhibitor |
5304 |
FICZ |
Facilitates
hPSC to HSC manufacture in vitro; also aryl hydrocarbon receptor (AhR)
agonist; |
1508 |
GW
9662 |
Promotes
HSCs expansion; increases HSCs engraftment; also PPARγ antagonist |
4840 |
KU
0060648 |
Enhances
HDR efficiency and attenuates NHEJ frequency; also dual DNA-PK and PI 3-K
inhibitor |
2197 |
L-755,507 |
Enhances
CRISPR-mediated HDR efficiency; also very potent and selective β3 partial
agonist |
7044 |
(±)-α-Lipoic
acid |
Maintains
function of HSCs in culture; also antioxidant |
6618 |
MB
05032 |
Promotes
HSCs expansion; also potent FBPase inhibitor |
4106 |
Nicotinamide |
Promotes
proliferation and expansion of HSC in vitro; also PARP1 inhibitor |
2828 |
NU
7026 |
Improves
HDR-mediated editing in HSCs; also selective DNA-PK inhibitor |
2296 |
Prostaglandin
E2 |
Promotes
HSCs expansion; increases HSCs engraftment |
6048 |
R-BC154 |
High
affinity fluorescent α4β1/α9β1 inhibitor; mobilizes HSCs |
4181 |
Ro
3306 |
Improves
HDR-mediated editing in HSCs; also Cdk1 inhibitor |
1202 |
SB
203580 |
Promotes
ex vivo expansion of HSC; also p38 MAPK inhibitor |
1614 |
SB
431542 |
Promotes
HSCs proliferation; also inhibitor of TGF-βRI, ALK4 and ALK7 |
5342 |
SCR7
pyrazine |
Enhances
HDR efficiency |
3784 |
Sildenafil
citrate |
Promotes
HSCs mobilization |
7086 |
StemRegenin
1 |
Promotes
HSC expansion and engraftment; also aryl hydrocarbon receptor (AhR)
antagonist |
5759 |
SW
033291 |
Promotes
HSCs expansion and engraftment; also high affinity 15-PGDH inhibitor |
3082 |
Tempol |
Maintains
HSC function in culture; also superoxide scavenger; Antioxidant |
3114 |
Troglitazone |
Inhibits
cell growth of hematopoietic cell lines; also selective PPARγ agonist;
antidiabetic agent |
6002 |
Trolox |
Maintains
HSC function in culture; also antioxidant E derivative; Antioxidant |
5493 |
XL
413 hydrochloride |
Improves
HDR-mediated editing in HSCs; also potent and selective Cdc7 inhibitor |